2002

Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation today announced that Thomas J. Linnemeier, M.D., FACC, senior vice president, new ventures and chief medical officer, Vascular...

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that the company has launched the HI-TORQUE BALANCE...

Largest Study to Date, DELIVER II Will Evaluate Clinical Benefit of ACHIEVE Stent in High-Risk Patients Indianapolis, Ind. and Brussels - Guidant Corporation (NYSE and PCX: GDT), a world leader in...

Only Approved Technology to Treat Both Sudden Cardiac Death and Heart Failure; Guidant to Hold Webcast Conference Call Today Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and...

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate in the Deutsche Bank...

New York, NY, and Santa Clara, CA - Clinsights Inc. today announced the launch of the Drug Eluting Stent Center (DESC) on TCTMD - the premier online community for interventional cardiologists and...

Guidant Awarded $158 Million In Damages Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, reported that an arbitration...

13 Percent Earnings Growth Leads to Earnings Per Share of $0.47, as Adjusted; Second Quarter Financial Guidance Reflects Enhanced Growth Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT),...

International Symposium Covers Latest Techniques and Technologies for Treating Coronary and Peripheral Vascular Disease Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and...

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate in the SunTrust Robinson...